Skip to main content
. 2009 Jul 28;2(9-10):467–478. doi: 10.1242/dmm.001438

Fig. 3.

Fig. 3.

FA supplementation with embryonic Wnt3A exposure at HH stages 3+/4 increases the percentage of normal heart development. Of the embryos in the control group, 58% displayed normal development in contrast to 18% of embryos in the Wnt3A-exposed group. FA supplementation increased the percentage of Wnt3A-exposed embryos with normal development to the level seen in the control group.